How to Stop Diarrhea With Pancreatic Cancer

Diarrhea in pancreatic cancer rarely has a single cause, which is exactly why a single remedy seldom fixes it. The tumor itself, the surgery to remove it, chemotherapy drugs, infections, and the loss of digestive enzyme production can all drive loose or frequent stools, sometimes simultaneously. Getting control usually means identifying which of these causes is at work and addressing each one, with pancreatic enzyme replacement therapy being the intervention that helps the largest number of patients.

Why Pancreatic Cancer Causes Diarrhea in So Many Different Ways

Your pancreas does two things: it makes hormones like insulin, and it produces digestive enzymes that break down fats, proteins, and carbohydrates. When a tumor grows in the pancreas, particularly in the head of the organ, it can block the pancreatic duct and choke off the flow of those enzymes into the small intestine. The gland tissue upstream of the blockage gradually wastes away, further reducing enzyme output. The result is a condition called exocrine pancreatic insufficiency, or EPI, which is extremely common in people with pancreatic cancer.¹ Without enough enzymes, fat passes through the gut undigested. That undigested fat pulls water into the intestine, producing greasy, foul-smelling, loose stools along with bloating, gas, weight loss, and deficiencies in fat-soluble vitamins.²

EPI is the most common driver of diarrhea in pancreatic cancer, but it is far from the only one. Surgery to remove part or all of the pancreas creates its own set of problems. Chemotherapy drugs, especially those in the FOLFIRINOX regimen, can directly damage the intestinal lining. Infections like Clostridioides difficile thrive in people whose gut flora has been disrupted by antibiotics and chemotherapy. And bacterial overgrowth in the small intestine is surprisingly frequent. Because multiple causes can overlap, you and your care team often have to work through them one at a time.

Pancreatic Enzyme Replacement Therapy

If EPI is the most common culprit, enzyme replacement is the most common solution. Pancreatic enzyme replacement therapy, usually called PERT, involves swallowing capsules of porcine-derived lipase, protease, and amylase with every meal and snack. These capsules do the work your pancreas can no longer do, breaking down fats and other nutrients before they reach the lower intestine. PERT is considered both safe and effective for treating EPI from pancreatic cancer and other causes.³

The dosing matters more than many patients realize. Guidelines recommend starting at 30,000 to 40,000 units of lipase with each full meal and about half that with snacks.³ The capsules should be split throughout the meal rather than taken all at once beforehand, because the enzymes need to mix with the food as it enters the stomach and duodenum. Many patients end up on doses that are too low. A systematic review of real-world prescribing found that even lower-than-recommended doses reduced diarrhea in most studies, but only guideline-compliant doses improved or maintained nutritional status.⁴ In other words, a low dose might make your stools firmer, but you could still be malnourished. If diarrhea persists on a starting dose, increasing it is usually the first step before looking for other explanations.

Diagnosing EPI itself typically involves measuring fecal elastase-1, an enzyme produced only by the pancreas. A low level in a stool sample confirms that your pancreas is not putting out enough enzymes.³ That said, many oncologists will start PERT empirically in pancreatic cancer patients with steatorrhea (fatty stools) because the pre-test probability of EPI is so high in this population. If symptoms improve, the diagnosis is essentially confirmed.

Diarrhea After Pancreatic Surgery

Surgery to remove pancreatic tumors, whether a Whipple procedure, a distal pancreatectomy, or a total pancreatectomy, frequently triggers diarrhea through mechanisms that go beyond simple enzyme loss. A retrospective study of 320 patients found that about one in five developed diarrhea after any type of pancreatectomy, but the rate climbed to roughly a third after total pancreatectomy and about a quarter after the Whipple procedure.⁵ A prospective study tracking patients at 7, 30, and 90 days after surgery found even higher rates: about half of Whipple patients and over 60 percent of total pancreatectomy patients had diarrhea at the 30-day mark.⁶

What makes post-surgical diarrhea especially tricky is that it has several contributing threads. Removing pancreatic tissue obviously reduces enzyme production, so PERT is needed. But the surgery also reroutes the digestive tract, which can lead to dumping syndrome, where food moves too quickly from the stomach remnant into the small intestine, triggering cramping, nausea, and watery diarrhea shortly after eating. Eating smaller, more frequent meals and cutting back on high-fat and high-sugar foods helps manage dumping syndrome in particular.

Vascular resection during surgery, which some patients need when the tumor involves nearby blood vessels, substantially raises the risk. Patients who underwent arterial divestment or resection had dramatically higher odds of developing post-surgical diarrhea.⁵ Quality of life suffers as well: urgency, abdominal discomfort, and even fecal incontinence are reported by a meaningful percentage of patients at the 30-day mark.⁶

When Nerve Damage Plays a Role

Surgeons performing the Whipple procedure sometimes need to dissect nerve tissue around the major arteries that feed the gut, particularly the superior mesenteric artery and the celiac artery. These nerve plexuses help regulate intestinal motility, the coordinated muscle contractions that move food through the digestive tract at the right speed. When they are disrupted, the gut can move contents through too fast, causing persistent diarrhea that does not respond well to enzyme replacement alone. In one study of 200 patients who underwent Whipple procedures, 39 percent developed refractory diarrhea, and over 93 percent of those patients had undergone extensive nerve dissection around the major arteries.⁷ This kind of diarrhea can be stubborn and long-lasting, often requiring medications that slow the gut rather than just replacing enzymes.

When Chemotherapy Is the Culprit

The chemotherapy regimens used in pancreatic cancer vary in how much gastrointestinal trouble they cause. FOLFIRINOX, a combination of four drugs that includes 5-fluorouracil and irinotecan, is one of the more aggressive regimens and is well known for causing diarrhea. Irinotecan in particular can damage the intestinal lining, leading to watery diarrhea that peaks a day or more after infusion. The 5-fluorouracil component adds its own risk of mucositis, where the rapidly dividing cells lining the gut are killed off by the drug alongside cancer cells.

Gemcitabine-based regimens, including gemcitabine paired with nab-paclitaxel, tend to cause less diarrhea. In a retrospective study of patients receiving gemcitabine/nab-paclitaxel as second-line therapy, severe diarrhea occurred in only about 3 percent of patients, compared to much higher rates for blood-related side effects like low platelets and anemia.⁸ That does not mean it never happens, but if you are on a gemcitabine-based regimen and experiencing significant diarrhea, other causes like EPI or infection deserve a close look before blaming the chemo.

For severe chemotherapy-induced diarrhea, oncologists will often reduce the dose in the next cycle. This is standard practice when a patient experiences a bad episode: reducing the offending drug’s dose is generally advised before continuing treatment.⁹ If a dose reduction is not desirable because the tumor is responding, prophylactic medication to prevent the next episode can sometimes be offered instead.

Infections That Complicate the Picture

Pancreatic cancer patients face a higher-than-normal risk of gut infections, and two in particular deserve attention: Clostridioides difficile (C. diff) and small intestinal bacterial overgrowth (SIBO).

C. diff is an opportunistic bacterium that flourishes when antibiotics or chemotherapy wipe out the normal bacteria that keep it in check. In a study of 200 patients with pancreatic ductal adenocarcinoma, C. diff infection was detected in 7.5 percent after surgery. Both preoperative chemotherapy and biliary tract infection were independently associated with a higher risk.¹⁰ C. diff produces toxins that inflame the colon, causing watery diarrhea that can become dangerous if untreated. The hallmark is diarrhea that smells distinctly foul, sometimes accompanied by fever and abdominal pain. A stool test can confirm the diagnosis, and treatment involves specific antibiotics that target C. diff while sparing normal flora as much as possible. If you develop sudden worsening diarrhea during or after chemotherapy, a C. diff test should be part of the workup, especially since local cancer recurrence itself may contribute to gut dysmotility and further increase infection risk.¹¹

SIBO is a condition where bacteria that normally live in the large intestine migrate into or overgrow in the small intestine, fermenting food before it can be properly absorbed. This produces gas, bloating, and diarrhea that can look a lot like EPI. In one study, the rate of SIBO in pancreatic cancer patients was over 63 percent, compared to about 13 percent in healthy controls.¹² SIBO is typically diagnosed with a breath test and treated with a course of antibiotics like rifaximin. Because it can coexist with EPI, some patients need both PERT and antibiotic treatment to get their diarrhea under control.

Anti-Diarrheal Medications Beyond Enzyme Replacement

When PERT alone does not do enough, or when the cause is not enzyme-related, additional medications come into play. Loperamide (the active ingredient in Imodium) is the most commonly used over-the-counter option, slowing gut motility and giving the intestine more time to absorb water. For many patients, loperamide combined with adequate PERT is enough.

For more stubborn cases, other options exist. Cholestyramine, a bile acid binder, can help if bile acid malabsorption is contributing to the diarrhea, which is plausible given evidence that bile acid signaling is disrupted in pancreatic cancer.¹³ Psyllium fiber can add bulk to stools. And for severe, treatment-resistant diarrhea, octreotide, a synthetic hormone that slows gut secretions and motility, has been used successfully. One case report described a patient with persistent diarrhea after a celiac plexus block who failed loperamide, hyoscine, psyllium, and cholestyramine before finally responding to octreotide.¹⁴ Octreotide is also used prophylactically in patients who have had severe chemotherapy-induced diarrhea to prevent recurrence in the next treatment cycle.⁹

Up to 37 percent of patients with post-surgical diarrhea needed anti-diarrheal medications in addition to PERT, underscoring that enzyme replacement is necessary but not always sufficient.⁶

Dietary Adjustments That Actually Help

Diet changes are not going to fix diarrhea on their own in pancreatic cancer, but they can meaningfully reduce the burden alongside medical therapy. The key principles are straightforward:

Smaller, more frequent meals: Five or six smaller meals are easier on a rearranged or enzyme-depleted digestive system than three large ones. Smaller volumes give your available enzymes and shortened gut a better chance of processing food before it moves on.
Moderate fat intake: Fat is the macronutrient most dependent on pancreatic enzymes for digestion. Reducing dietary fat, at least until PERT dosing is optimized, can ease steatorrhea. This does not mean eliminating fat entirely, because fat carries essential calories and nutrients that cancer patients need.
Limiting simple sugars: High-sugar foods and drinks can worsen dumping syndrome after surgery by pulling water into the intestine through osmosis. Spreading sugar intake throughout the day and pairing it with protein or fat slows absorption.
Staying hydrated: Diarrhea drains fluid and electrolytes rapidly. Oral rehydration solutions, broth, and electrolyte drinks help replace what is lost. Dehydration in a cancer patient can spiral quickly into kidney problems and dangerous electrolyte imbalances.

Working with a registered dietitian who has experience in oncology is one of the more practical things you can do. They can help you maintain adequate calorie intake while adjusting the composition of your diet to minimize diarrhea. Enteral nutrition, meaning supplemental nutrition delivered through the gut by mouth or feeding tube, is generally preferred over intravenous (parenteral) nutrition when the digestive tract is functional.¹⁵ Keeping the gut working, even imperfectly, helps maintain its structural integrity and reduces the risk of bacterial translocation.

When to Raise the Alarm

Not all diarrhea in pancreatic cancer is created equal. Some episodes are an expected nuisance that responds to dose adjustments and dietary changes. Others signal something dangerous that requires immediate medical attention. You should contact your oncology team urgently if you notice any of the following:

High-volume watery stools: More than six to eight episodes in 24 hours, or large-volume output that leaves you visibly dehydrated (dark urine, dizziness on standing, dry mouth).
Bloody stools: Blood or dark tarry stools could indicate C. diff colitis, intestinal ischemia, or other complications that need evaluation.
Fever: Diarrhea plus fever in a person on chemotherapy could mean infection, including C. diff or neutropenic enterocolitis, both of which are medical emergencies.
Inability to keep fluids down: If nausea or vomiting accompanies the diarrhea and you cannot drink enough to stay hydrated, intravenous fluids may be needed.

Post-surgical diarrhea that does not improve within a few weeks, or worsens after initially getting better, also warrants a fresh conversation with your surgical and oncology teams. It may point to an overlooked infection, SIBO, or the need to adjust PERT doses. Diarrhea that persists despite adequate enzyme replacement should prompt investigation for other causes rather than simply escalating the dose indefinitely.

Probiotics and the Microbiome

The idea of using probiotics to prevent or treat cancer-related diarrhea has generated a lot of interest, but the evidence remains mixed. A systematic review and meta-analysis looking at probiotics for preventing diarrhea caused by chemoradiotherapy in abdominal and pelvic cancers found no significant increase in side effects from the probiotics themselves, suggesting they are at least safe for most patients.¹⁶ Whether they actually reduce diarrhea enough to matter in pancreatic cancer specifically is less clear, since most of the trials included mixed cancer types and treatment regimens.

There is a legitimate theoretical basis for probiotic benefit here. The gut microbiome in pancreatic cancer patients is altered, with changes in bile acid metabolism and increased rates of bacterial overgrowth as described earlier. Restoring a healthier microbial balance could plausibly improve symptoms. But probiotics should not be used in patients who are severely immunocompromised or neutropenic, because even “friendly” bacteria can cause bloodstream infections in someone without a functioning immune defense. If you are interested in trying probiotics, discuss the timing with your oncologist so that you avoid periods of peak immune suppression after chemotherapy.

The broader point about the microbiome is that pancreatic cancer disrupts it in multiple ways, from altered bile acid signaling to antibiotic exposure to the anatomical rearrangements of surgery.¹³ This disruption contributes to diarrhea in ways that are still being worked out, and it explains why simple interventions like a single probiotic strain or a single medication often do not fully resolve the problem. Managing diarrhea in pancreatic cancer is almost always a layered effort: enzymes as the foundation, dietary modifications on top, targeted medications for specific causes, and close communication with your care team to adjust the approach as treatment evolves.